GALNT14 and esophageal squamous cell carcinoma: In addition to the correlation between GALNT14-rs9679162 and chemotherapy treatment outcomes in HCC, the predictive role of GALNT14-rs9679162 has also been demonstrated in several other types of GI cancers, including cholangiocarcinoma, colorectal cancer, gastric signet ring cell cancer, and esophageal squamous cell cancer.